Jump to main content
Jump to site search


Novel anti-HER2 Peptide conjugated Theranostic Nanoliposome combining NaYF4:Yb,Er nanoparticles for NIR-activated Bioimaging and Chemo-Photodynamic therapy against Breast Cancer

Abstract

Herein, we report the fabrication of novel peptide conjugated Ligand targeted nanoliposomes (LTLs) for chemo-photodynamic therapy against HER2-positive breast cancer. The LTL core was utilized for encapsulating doxorubicin (DOX) for chemotherapy, and methylene blue (MB) attached NaYF4:Yb,Er upconversion nanoparticles (UCNPs) for NIR activated bioimaging and leveraging its visible emission for photoexciting MB for enhanced photodynamic therapy (PDT). The specificity of our LTLs was achieved by conjugating a newly discovered anti-HER2 peptide screened from a phage display peptide library. The high selectivity of the peptide conjugated LTLs was confirmed by confocal imaging of SKBR-3 (HER2-positive) and MCF-7 (HER2-negative) breast cancer cell lines, illustrating its target-specific nature. The energy transfer from UCNPs to MB was verified, enabling the generation of reactive oxygen species upon activation with a 975 nm laser source (0.60 W/cm-2) under 5 min continuous excitation. A significant decline in the cell viability by 95% was observed using a chemo-photodynamic combinational therapy, whereas for chemo-drug alone and PDT alone, the cell proliferation was declined by 77% and 84%, respectively. Furthermore, we demonstrated an improved uptake of the LTLs inside a 3D model of SKBR-3 tumor spheroids, where the spheroid cell viability was suppressed by 66% after the use of chemo-photodynamic combinational therapy. Thus, our results suggest great prospective for the use of theranostic LTLs for breast cancer management.

Back to tab navigation

Supplementary files

Publication details

The article was received on 30 Jul 2019, accepted on 06 Oct 2019 and first published on 10 Oct 2019


Article type: Paper
DOI: 10.1039/C9NR06535K
Nanoscale, 2019, Accepted Manuscript

  •   Request permissions

    Novel anti-HER2 Peptide conjugated Theranostic Nanoliposome combining NaYF4:Yb,Er nanoparticles for NIR-activated Bioimaging and Chemo-Photodynamic therapy against Breast Cancer

    S. S. Panikar, G. Ramírez-García, A. A. Vallejo-Cardona, N. Banu, A. A. Patron, D. Cialla-May, T. Camacho Villegas and E. DE LA ROSA, Nanoscale, 2019, Accepted Manuscript , DOI: 10.1039/C9NR06535K

Search articles by author

Spotlight

Advertisements